Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report.
Goss
P E
PE
Department of Hematology/Oncology, Toronto Hospital, Ontario, Canada.
Burkes
R
R
Rudinskas
L
L
King
M
M
Chow
W
W
Myers
R
R
Davidson
M
M
Poldre
P
P
Crump
M
M
Sutton
D
D
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D011446:Prospective Studies
D005047:Etoposide; D008942:Mitoxantrone; D011241:Prednisone